Comparative effectiveness of biologic agents for the treatment of psoriasis

The IL-12/23 inhibitor ustekinumab is now an established effective treatment for psoriasis. Dr Bruce Strober discusses the effectiveness of ustekinumab for psoriasis in the context of traditional anti-TNF treatment, using real-world data from the large PSOLAR patient registry. Find out more at: http://www.dermatology-education.com/... View Dr Bruce Strober's profile at: http://www.dermatology-education.com/... Dermatology Education is directed by internationally renowned experts in dermatology who will provide regular clinical perspectives on the latest publications, congress presentations, treatment guidelines and other information addressing the challenges faced by dermatologists in the clinic. The views expressed here are those of the contributors and do not reflect those of either FIDE or The Fishawack Group of Companies. The content has been developed for specialist dermatologists only. It is intended to help them with their own professional development and research and should not be relied upon for making individual clinical decisions, which are the responsibility of the treating clinicians. The opinions expressed during this presentation are solely those of Dr Bruce Strober, and do not constitute or imply endorsement by the University of Connecticut Health Center or School of Medicine.